Phreesia, Inc.
Phreesia, Inc. (PHR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHR · as of Jun 8, 2026
Key Statistics
Explore Phreesia, Inc. Data
phr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 72.0%
The PHR analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing +61.38% upside from the current price of $9.29.
Competitors & Peers
phr competitorsPHR
BLFS
ESTA
GDRX
KMTS
NEOGStock Performance
Full HistoryAbout Phreesia, Inc.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phr…
what is phreesia, inc. · phr stock overview · phreesia, inc. company profile · who is phreesia, inc. ceo · phr NYSE · phreesia, inc. headquarters · phreesia, inc. business segments
About Stock Overview & Key Data
Phreesia, Inc. (PHR) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NYSE since Jul 18, 2019. As of the latest trading session, PHR stock price is $9.29, with a market capitalization of $574.5M. The stock has returned -66.20% over the past 12 months and -45.07% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Phreesia, Inc. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2026, Phreesia, Inc. reported revenue of $480.6M and net income of $2.3M. For detailed data — including Phreesia, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Phreesia, Inc. (PHR) stock price is $9.29. The stock is traded on NYSE under the ticker symbol PHR. The 52-week range is $7.77 – $32.76.